For: | Quetglas EG, Mujagic Z, Wigge S, Keszthelyi D, Wachten S, Masclee A, Reinisch W. Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease. World J Gastroenterol 2015; 21(44): 12519-12543 [PMID: 26640330 DOI: 10.3748/wjg.v21.i44.12519] |
---|---|
URL: | https://www.wjgnet.com/2220-315x/full/v21/i44/12519.htm |
Number | Citing Articles |
1 |
Kijae Jo, Kwang Woo Kim, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim, Seong-Joon Koh. Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study. Intestinal Research 2024; 22(4): 453 doi: 10.5217/ir.2024.00044
|
2 |
Rocío Prieto-Pérez, Berta Almoguera, Teresa Cabaleiro, Hakon Hakonarson, Francisco Abad-Santos. Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease. International Journal of Molecular Sciences 2016; 17(2): 225 doi: 10.3390/ijms17020225
|
3 |
Liliana Lykowska-Szuber, Michal Walczak, Agnieszka Dobrowolska, Marzena Skrzypczak-Zielinska. Apoptosis and inflammatory genes variants in primary non-response to anti-TNF therapy in Crohn’s disease patients. European Journal of Gastroenterology & Hepatology 2023; 35(10): 1088 doi: 10.1097/MEG.0000000000002618
|
4 |
Yan‐ming Li, Jing‐zhong Liao, Zi‐juan Jian, Hong‐ling Li, Xia Chen, Qing‐xia Liu, Pei‐lin Liu, Zhi‐qian Wang, Xuan Liu, Qun Yan, Wen‐en Liu. Molecular epidemiology and clinical characteristics of Clostridioides difficile infection in patients with inflammatory bowel disease from a teaching hospital. Journal of Clinical Laboratory Analysis 2022; 36(12) doi: 10.1002/jcla.24773
|
5 |
Sha-Sha Tao, Fan Cao, Napoleon Bellua Sam, Hong-Miao Li, Ya-Ting Feng, Jing Ni, Peng Wang, Xiao-Mei Li, Hai-Feng Pan. Dickkopf-1 as a promising therapeutic target for autoimmune diseases. Clinical Immunology 2022; 245: 109156 doi: 10.1016/j.clim.2022.109156
|
6 |
Dhirendra Singh, Randhir Singh. Exploration of Pharmacological Potential of Alpinetin. Current Nutrition & Food Science 2023; 19(3): 238 doi: 10.2174/1573401318666220512162233
|
7 |
HANNE Salmenkari, ANITA LAITINEN, RICHARD A. FORSGÅRD, MERVI HOLAPPA, JERE LINDÉN, LAURI PASANEN, MATTI KORHONEN, RIITTA KORPELA, JOHANNA NYSTEDT. The use of unlicensed bone marrow–derived platelet lysate–expanded mesenchymal stromal cells in colitis: a pre-clinical study. Cytotherapy 2019; 21(2): 175 doi: 10.1016/j.jcyt.2018.11.011
|
8 |
G. Leoncini, F. Donato, L. Reggiani-Bonetti, T. Salviato, M. Cadei, M. Daperno, M. B. Principi, A. Armuzzi, F. Caprioli, G. Canavese, V. Villanacci, L. Albarello, A. Andorno, M. R. Aprile, M. C. Aquilano, L. Baron, S. Battista, G. Becchina, D. Bellis, E. Biletta, M. R. D’Ambrosio, E. David, R. Del Sordo, M. Facchetti, M. Fortunato, M. C. Giustiniani, D. Piscitelli, L. Saragoni, G. Tanzi. Diagnostic interobserver variability in Crohn’s disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group. Techniques in Coloproctology 2021; 25(1): 101 doi: 10.1007/s10151-020-02349-9
|
9 |
Emre GERÇEKER, Serkan CERRAH, Ahmet BAYKAN. Helicobacter pylori ve inflamatuvar bağırsak hastalığı arasındaki ilişki. Akademik Gastroenteroloji Dergisi 2021; 20(2): 65 doi: 10.17941/agd.975765
|
10 |
Emre Gerçeker, Hakan Yüceyar, Elmas Kasap, Ufuk Demirci, Burcu Ceren Ekti, İsmet Aydoğdu, Mine Miskioğlu. Treatment of inflammatory bowel disease by leukocytapheresis. Transfusion and Apheresis Science 2017; 56(3): 421 doi: 10.1016/j.transci.2017.03.016
|
11 |
Raffaella Franca, Debora Curci, Marianna Lucafò, Giuliana Decorti, Gabriele Stocco. Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2019; 15(7): 527 doi: 10.1080/17425255.2019.1630378
|
12 |
Marianna Lucafò, Raffaella Franca, Davide Selvestrel, Debora Curci, Letizia Pugnetti, Giuliana Decorti, Gabriele Stocco. Pharmacogenetics of treatments for inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(12): 1209 doi: 10.1080/17425255.2018.1551876
|
13 |
Yue Tan, Changqing Zheng. Effects of Alpinetin on Intestinal Barrier Function, Inflammation and Oxidative Stress in Dextran Sulfate Sodium-Induced Ulcerative Colitis Mice. The American Journal of the Medical Sciences 2018; 355(4): 377 doi: 10.1016/j.amjms.2018.01.002
|
14 |
Pranay Wal, Namra Aziz, Aman Patel, Ankita Wal. An Updated Review of Nicotine in Gastrointestinal Diseases. The Open Public Health Journal 2023; 16(1) doi: 10.2174/0118749445271127231116130459
|
15 |
Ling-chang Tong, Yue Wang, Zhi-bin Wang, Wei-ye Liu, Sheng Sun, Ling Li, Ding-feng Su, Li-chao Zhang. Propionate Ameliorates Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Reducing Inflammation and Oxidative Stress. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00253
|
16 |
Sarah E. Kralicek, Mai Nguyen, Ki-Jong Rhee, Rocio Tapia, Gail Hecht. EPEC NleH1 is significantly more effective in reversing colitis and reducing mortality than NleH2 via differential effects on host signaling pathways. Laboratory Investigation 2018; 98(4): 477 doi: 10.1038/s41374-017-0016-1
|
17 |
Juan Shi, Shuhong Chi, Jing Xue, Jiali Yang, Feng Li, Xiaoming Liu. Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases. Journal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/9392132
|
18 |
Sereen Mahasneh, Ahmad Sharab, Mohammad Al Shhab, Mohammad Rashid, Malek Zihlif. AOX1 and XDH Enzymes Genotyping and its Effect on Clinical Response to Azathioprine in Inflammatory Bowel Disease Patients Among Jordanian Population. Current Drug Metabolism 2020; 21(2): 140 doi: 10.2174/1389200221666200413125011
|
19 |
Shuang Cui, Peng-Yu Chang. Current understanding concerning intestinal stem cells. World Journal of Gastroenterology 2016; 22(31): 7099-7110 doi: 10.3748/wjg.v22.i31.7099
|
20 |
Yuan Wang, Ying Mao, Junfeng Zhang, Gang Shi, Lin Cheng, Yi Lin, Yiming Li, Xiaomei Zhang, Yujing Zhang, Xiaolei Chen, Jie Deng, Xiaolan Su, Lei Dai, Yang Yang, Shuang Zhang, Dechao Yu, Yuquan Wei, Hongxin Deng. IL‐35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells. Journal of Cellular and Molecular Medicine 2018; 22(2): 1014 doi: 10.1111/jcmm.13428
|
21 |
Garth R. Swanson, Mary Biglin, Hannah Raff, Vijit Chouhan, Sarah Jochum, Maliha Shaikh, Lauren Francey, Faraz Bishehsari, John Hogenesch, Ali Keshavarzian. Impact of Chronotherapy on 6-Mercaptopurine Metabolites in Inflammatory Bowel Disease: A Pilot Crossover Trial. Clinical and Translational Gastroenterology 2023; 14(2): e00549 doi: 10.14309/ctg.0000000000000549
|
22 |
Wuwen Feng, Hui Ao, Shijun Yue, Cheng Peng. Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34509-1
|
23 |
Salih Boga, Huseyin Alkim, Ali Riza Koksal, Ayse Aysim Ozagari, Mehmet Bayram, Sebnem Tekin Neijmann, Ilker Sen, Canan Alkim. Serum St2 in Inflammatory Bowel Disease: A Potential Biomarker for Disease Activity. Journal of Investigative Medicine 2016; 64(5): 1016 doi: 10.1136/jim-2016-000062
|
24 |
Cynthia Morvillo, Katherine Vinci, Lauren Hedenschoug, Leah Mancini, Carrie Mize, Kayce Tugg, Steven Stein. Risks and Safety of Advanced Therapies and Biologics in Inflammatory Bowel Disease. Gastroenterology Nursing 2020; 43(4): E159 doi: 10.1097/SGA.0000000000000523
|